AU7105996A - Bacterial delivery system - Google Patents

Bacterial delivery system

Info

Publication number
AU7105996A
AU7105996A AU71059/96A AU7105996A AU7105996A AU 7105996 A AU7105996 A AU 7105996A AU 71059/96 A AU71059/96 A AU 71059/96A AU 7105996 A AU7105996 A AU 7105996A AU 7105996 A AU7105996 A AU 7105996A
Authority
AU
Australia
Prior art keywords
delivery system
bacterial delivery
bacterial
delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU71059/96A
Other versions
AU731061B2 (en
Inventor
Arthur A. Branstrom
Jerald C. Sadoff
Donata R. Sizemore
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Army
Original Assignee
US Department of Army
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/523,855 external-priority patent/US5824538A/en
Application filed by US Department of Army filed Critical US Department of Army
Publication of AU7105996A publication Critical patent/AU7105996A/en
Application granted granted Critical
Publication of AU731061B2 publication Critical patent/AU731061B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0283—Shigella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
AU71059/96A 1995-09-06 1996-09-06 Bacterial delivery system Ceased AU731061B2 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US331895P 1995-09-06 1995-09-06
US08/523855 1995-09-06
US08/523,855 US5824538A (en) 1995-09-06 1995-09-06 Shigella vector for delivering DNA to a mammalian cell
US60/003318 1995-09-06
US1803596P 1996-05-21 1996-05-21
US60/018035 1996-05-21
PCT/US1996/014190 WO1997008955A1 (en) 1995-09-06 1996-09-06 Bacterial delivery system

Publications (2)

Publication Number Publication Date
AU7105996A true AU7105996A (en) 1997-03-27
AU731061B2 AU731061B2 (en) 2001-03-22

Family

ID=27357382

Family Applications (1)

Application Number Title Priority Date Filing Date
AU71059/96A Ceased AU731061B2 (en) 1995-09-06 1996-09-06 Bacterial delivery system

Country Status (6)

Country Link
EP (1) EP0881884A4 (en)
JP (1) JP2000500734A (en)
AU (1) AU731061B2 (en)
CA (1) CA2231332C (en)
IL (1) IL123569A (en)
WO (1) WO1997008955A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0977874B1 (en) * 1997-04-18 2005-11-09 Gesellschaft für biotechnologische Forschung mbH (GBF) Attenuated salmonella strain used as a vehicle for oral immunization
US6080849A (en) 1997-09-10 2000-06-27 Vion Pharmaceuticals, Inc. Genetically modified tumor-targeted bacteria with reduced virulence
CN1253551C (en) 1997-09-10 2006-04-26 维昂药品公司 Genetically modified tumor-targeted bacteria with reduced virulence
US6368604B1 (en) 1997-09-26 2002-04-09 University Of Maryland Biotechnology Institute Non-pyrogenic derivatives of lipid A
JP2001519162A (en) 1997-10-07 2001-10-23 ユニバーシティ・オブ・メリーランド・バイオテクノロジー・インスティチュート Method for introducing and expressing RNA in animal cells
DE19754938B4 (en) 1997-12-11 2006-04-20 Christoph von Dr. Eichel-Streiber TGC method for induction of targeted, somatic transgenicity
US6825028B1 (en) * 1998-12-11 2004-11-30 Christoph Von Eichel-Streiber Recombinant listeria
US6143551A (en) * 1997-12-29 2000-11-07 Schering Aktiengesellschaft Delivery of polypeptide-encoding plasmid DNA into the cytosol of macrophages by attenuated listeria suicide bacteria
CU22661A1 (en) * 1997-12-30 2001-04-27 Cnic Ct Nac Investigaciones NEW VACCINE CANDIDATES OF VIBRIO CHOLERAE AND METHOD OF OBTAINING
US6596477B1 (en) 1998-09-28 2003-07-22 University Of Maryland Biotechnology Institute Treatment and prevention of immunodeficiency virus infection by administration of non-pyrogenic derivatives of lipid A
BR0014491A (en) * 1999-10-04 2004-03-09 Vion Pharmaceuticals Inc Tumor-marked attenuated bacteria, pharmaceutical composition, use of attenuated bacteria, and fusion protein
US6962696B1 (en) 1999-10-04 2005-11-08 Vion Pharmaceuticals Inc. Compositions and methods for tumor-targeted delivery of effector molecules
AU2005310119A1 (en) * 2004-11-30 2006-06-08 Aeras Global Tb Vaccine Foundation Bacterial packaging strains useful for generation and production of recombinant double-stranded RNA nucleocapsids and uses thereof
US20090123426A1 (en) * 2004-12-17 2009-05-14 Chiang Li Compositions for Bacterial Mediated Gene Silencing and Methods of Using the Same
US9597379B1 (en) 2010-02-09 2017-03-21 David Gordon Bermudes Protease inhibitor combination with therapeutic proteins including antibodies
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5077044A (en) * 1980-05-19 1991-12-31 The Board Of Trustees Of The Leland Stanford Jr. University Novel non-reverting shigella live vaccines
US4632830A (en) * 1981-07-31 1986-12-30 The United States Of America As Represented By The Secretary Of The Army Oral vaccine for immunization against enteric disease
AR242989A1 (en) * 1988-07-15 1993-06-30 Inst Pasteur I Nat De La Sante A method for modifying a wild strain of a "shigella", in order to produce a modified strain suitable for preparing a vaccine against the wild strain, and a "shigella" strain thus modified.

Also Published As

Publication number Publication date
IL123569A0 (en) 1998-10-30
EP0881884A4 (en) 2004-07-14
EP0881884A1 (en) 1998-12-09
CA2231332C (en) 2007-04-17
JP2000500734A (en) 2000-01-25
WO1997008955A1 (en) 1997-03-13
IL123569A (en) 2006-10-05
CA2231332A1 (en) 1997-03-13
AU731061B2 (en) 2001-03-22

Similar Documents

Publication Publication Date Title
AU5441496A (en) Fluid Delivery System
AU3739697A (en) Gene delivery system
AU4129396A (en) Diketopiperazine-based delivery systems
AU7310696A (en) Dsplay system
AU7070796A (en) Modular system
AU6936896A (en) Messaging system
AU2816297A (en) Recipient-dosage delivery system
AU3745395A (en) Microorganisms as therapeutic delivery systems
AU7245196A (en) Aeration system
AU2754497A (en) Flavor delivery system
AU4348196A (en) Multimedia telemanaging system
AU3257495A (en) Molecular presenting system
AU7229396A (en) Transport system
AU6488596A (en) Comprehensive product delivery system
AU7105996A (en) Bacterial delivery system
AU5668096A (en) Modular engine delivery system
AU6146096A (en) Conveyor system
AU5105398A (en) Hydrocolloid delivery system
AU1671997A (en) Drug delivery system using galactoxyloglucan
AU3991695A (en) Ranging system
AU7311796A (en) Ventilation system
AU7164996A (en) Constituent delivery system
AU2316997A (en) Liposomal delivery system
AU7311696A (en) Ventilation system
AU5404996A (en) Construction system

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired
NA Applications received for extensions of time, section 223

Free format text: AN APPLICATION TO EXTEND THE TIME FROM 20010906 TO 20020106 IN WHICH TO PAY A RENEWAL FEE HAS BEEN LODGED

NB Applications allowed - extensions of time section 223(2)

Free format text: THE TIME IN WHICH TO PAY A RENEWAL FEE HAS BEEN EXTENDED TO 20020106